Substance / Medication

Chlorpromazine

Overview

Active Ingredient
chlorpromazine
RxNorm CUI
2403

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

3 trials linked to this intervention

3
Total Trials
0
Recruiting
1
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Chlorpromazine versus piperacetazine for schizophrenia.
Eslami Shahrbabaki Mahin, Dehnavieh Reza, Vali Leila et al. · Cochrane Database Syst Rev · 2018
PMID: 30378678Meta-AnalysisFull text (PMC)
Chlorpromazine dose for people with schizophrenia.
Dudley Katharine, Liu Xiaomeng, De Haan Saskia · Cochrane Database Syst Rev · 2017
PMID: 28407198Meta-AnalysisFull text (PMC)
Chlorpromazine versus penfluridol for schizophrenia.
Nikvarz Naemeh, Vahedian Mostafa, Khalili Navid · Cochrane Database Syst Rev · 2017
PMID: 28940256Meta-AnalysisFull text (PMC)
Chlorpromazine versus metiapine for schizophrenia.
Zare Morteza, Bazrafshan Azam · Cochrane Database Syst Rev · 2017
PMID: 28349512Meta-AnalysisFull text (PMC)
Chlorpromazine versus clotiapine for schizophrenia.
Mazhari Shahrzad, Esmailian Saeed, Shah-Esmaeili Armita et al. · Cochrane Database Syst Rev · 2017
PMID: 28387925Meta-AnalysisFull text (PMC)
Chlorpromazine vs Reserpine for Schizophrenia.
Nur Selin, Adams Clive E · Schizophr Bull · 2016
PMID: 27098890Meta-AnalysisFull text (PMC)
Chlorpromazine versus reserpine for schizophrenia.
Nur Selin, Adams Clive E · Cochrane Database Syst Rev · 2016
PMID: 27124109Meta-AnalysisFull text (PMC)
Chlorpromazine versus atypical antipsychotic drugs for schizophrenia.
Saha Kumar B, Bo Li, Zhao Sai et al. · Cochrane Database Syst Rev · 2016
PMID: 27045703Meta-AnalysisFull text (PMC)
Chlorpromazine versus placebo for schizophrenia.
Adams Clive E, Awad George A, Rathbone John et al. · Cochrane Database Syst Rev · 2014
PMID: 24395698Meta-AnalysisFull text (PMC)
Chlorpromazine for psychosis induced aggression or agitation.
Ahmed Uzair, Jones Hannah, Adams Clive E · Cochrane Database Syst Rev · 2010
PMID: 20393959Meta-AnalysisFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Chlorpromazine (substance)
SNOMED CT
387258005
UMLS CUI
C0008286
RxNorm CUI
2403

Clinical Data

This intervention maps to 13 entities in the Healos knowledge graph.

8
Conditions
1
Biomarkers
2
Specialists
0
Symptoms
3
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Chlorpromazine — Conditions, Biomarkers & Specialists | Healos | Healos